Bispecific T-cell engagers in oral cancer immunotherapy

Bispecific T-cell engagers in oral cancer immunotherapy

•Development of BiTEs has revolutionized the way we treat oral cancer.•Ability to combat cancers is increased on combination with immune twisitng medications such as immunological check point inhibitors or conventional chemotherapy with BiTE therapy.•A positive development for individualized cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology reports 2024-06, Vol.10, p.100255, Article 100255
1. Verfasser: Vishnu Priya, Veeraraghavan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Development of BiTEs has revolutionized the way we treat oral cancer.•Ability to combat cancers is increased on combination with immune twisitng medications such as immunological check point inhibitors or conventional chemotherapy with BiTE therapy.•A positive development for individualized cancer care and a ray of hope for people receiving difficult diagnosis.
ISSN:2772-9060
2772-9060
DOI:10.1016/j.oor.2024.100255